U.S. Clinical Trial Supplies Market Research Report 2022 – Forecast to 2027: Growing Demand for Innovative Solutions in Clinical Trial Services – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Supplies Market Research Report by Services (Comparative Supply, Logistics & Distribution & Manufacturing), Type, Phase, Therapeutic Area, End User, State – United States, Forecast to 2027 – Impact aggregate of COVID-19″ report has been added to from ResearchAndMarkets.com offer.

The US clinical trial supplies market size was estimated at USD 5,661.62 million in 2021, USD 6,090.81 million in 2022, and is projected to grow at a compound annual growth rate (CAGR) of 7.66 % to reach USD 8,818.82 million by 2027.

In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year and the years from 2023 to 2027 as the forecast period.

Cumulative impact of COVID-19:

The report provides insights into COVID-19 considering shifts in consumer behavior and demand, shopping patterns, supply chain rerouting, current market force dynamics, and significant interventions governments. The updated study provides insights, analysis, estimates, and forecasts considering the impact of COVID-19 on the market.

Competitive Strategy Window:

The strategic competitive window analyzes the competitive landscape in terms of markets, applications and geographies to help the vendor define an alignment or match between its capabilities and opportunities for future growth prospects.

It describes the optimal or favorable fit for vendors to adopt successive strategies of merger and acquisition, geographic expansion, research and development, and new product introduction strategies to execute further business expansion and growth. during a forecast period.

FPNV positioning matrix:

The FPNV Positioning Matrix evaluates and ranks vendors in the clinical trial supplies market based on business strategy (business growth, industry coverage, financial viability, and channel support) and product satisfaction (value for money, ease of use, product features and customer). Support) that helps businesses make better decisions and understand the competitive landscape.

Market share analysis:

The market share analysis offers the analysis of the vendors considering their contribution to the overall market. It gives the idea of ​​its revenue generation in the overall market compared to other providers in the space. It provides information on the performance of vendors in terms of revenue generation and customer base compared to others.

Knowing the market share gives an idea of ​​the size and competitiveness of suppliers for the reference year. It reveals the characteristics of the market in terms of accumulation, fragmentation, dominance and merger.

Competitive scenario:

The competitive scenario provides an analysis of the prospects of the different business growth strategies adopted by the vendors.

The competitive scenario represents press releases or company news categorized into merger and acquisition, agreement, collaboration and partnership, new product launch and improvement, investment and funding, and awards, recognition and expansion. All the news gathered helps the vendor to understand the gaps in the market and the strength and weakness of the competitors, thus providing insights to improve the product and service.

Enterprise Usability Profiles:

The report provides information about the following pointers:

  • Biocair

  • Catalent, Inc.

  • Eurofins Scientific, Inc.

  • infosys limited

  • Liveo Research GmbH

  • Brand

  • Myonex, Inc.

  • Parexel International

  • Piramal pharmaceutical solutions

  • PRA Health Sciences

  • Thermo Fisher Scientific

  • UDG Healthcare plc

Main topics covered:

1. Preface

1.1. Study objectives

1.2. Market segmentation and coverage

1.3. Years Considered for Study

1.4. Currency and price

1.5. Tongue

1.6. Boundaries

1.7. Hypotheses

1.8. Stakeholders

2. Research methodology

2.1. Define: research objective

2.2. Determine: research design

2.3. Prepare: finding aid

2.4. Collect: Data Source

2.5. Analysis: Interpretation of data

2.6. Formula: data verification

2.7. Publish: Research report

2.8. Repeat: report update

3. Executive Summary

4. Market Overview

5. Market Overview

5.1. Market dynamics

5.1.1. Drivers

5.1.1.1. Growing Prevalence of Chronic Diseases in the United States

5.1.1.2. Increase in R&D spending by pharmaceutical and biopharmaceutical companies in the United States

5.1.2. Constraints

5.1.2.1. High cost of drug development

5.1.3. Opportunities

5.1.3.1. Growing demand for innovative solutions in clinical trial services in the United States

5.1.3.2. Increase in R&D investments for the development and research of new drugs

5.1.4. Challenges

5.1.4.1. Lack of qualified people to operate devices during clinical trials

5.2. Cumulative impact of COVID-19

6. Clinical Trial Supplies Market, By Service

6.1. Introduction

6.2. Sourcing comparator

6.3. Logistics & Distribution

6.3.1. Cold chain distribution

6.3.2. Distribution outside the cold chain

6.4. Manufacturing

6.5. Packaging, labeling and blinding

6.6. Storage and preservation

7. Clinical Trial Supplies Market, By Type

7.1. Introduction

7.2. Biological drugs

7.3. Medical equipement

7.4. small molecules

8. Clinical Trial Supplies Market, By Phase

8.1. Introduction

8.2. BA/BE studies

8.3. Stage 1

8.4. Phase 2

8.5. Phase 3

8.6. Phase 4

9. Clinical Trial Supplies Market, By Therapeutic Area

9.1. Introduction

9.2. Blood disorders

9.3. Cardiovascular illnesses

9.4. CNS and mental disorders

9.5. Dermatological disorders

9.6. Digestive disorders

9.7. ENT diseases

9.8. Immunology

9.9. Infectious diseases

9.10. Metabolic disorders

9.11. Nephrology

9.12. Oncology

9.13. Rare diseases

9.14. Respiratory disorders

10. Clinical Trial Supplies Market, By End User

10.1. Introduction

10.2. Contract Research Organizations (CROs)

10.3. Medical device companies

10.4. Pharmaceutical and biotechnology companies

11. California Clinical Trial Supplies Market

12. Florida Clinical Trial Supplies Market

13. Illinois Clinical Trial Supplies Market

14. New York Clinical Trial Supplies Market

15. Ohio Clinical Trial Supplies Market

16. Pennsylvania Clinical Trial Supplies Market

17. Texas Clinical Trial Supplies Market

18. Competitive Landscape

18.1. FPNV positioning matrix

18.1.1. Quadrants

18.1.2. Business strategy

18.1.3. Product Satisfaction

18.2. Market Ranking Analysis

18.3. Market share analysis, by key player

18.4. Competitive scenario

18.4.1. Merger & Acquisition

18.4.2. Agreement, collaboration and partnership

18.4.3. Launching and improving new products

18.4.4. Investment & Financing

18.4.5. Reward, recognition and expansion

19. Company Usability Profiles

For more information on this report, visit https://www.researchandmarkets.com/r/mvgva1

Comments are closed.